PRevention of OsTEoporotiC FracTure 2 Pilot Study

Recruiting N/A Interventional Study
Fragility Fracture
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
50 (estimated)
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
With the aging of the world population, osteoporosis and fragility fractures have become global public health concerns. It has been estimated the population of people ≥60 years of age will increase from 229 million (16.2%) in 2017 to 479 million (35.1%) by 2050 in China. Because age is an important predictor of osteoporosis and fragility fracture, the incidence of fragility fracture has increased …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Local residents (live in the city where the hospital is located for half a year or more); 2. Hospitalized patients with fractures aged 50 years and above; 3. First fracture, without history of fracture; 4. Never diagnosed as "osteoporosis" before admission; 5. No fracture his…
Contacts

Jian Mo, MD

+86 (020) 85252900

mojian3@mail.sysu.edu.cn

CONTACT